North Tide Capital as of June 30, 2017
Portfolio Holdings for North Tide Capital
North Tide Capital holds 12 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tivity Health | 22.2 | $100M | 2.5M | 39.85 | |
| Select Medical Holdings Corporation (SEM) | 17.1 | $77M | 5.0M | 15.35 | |
| Gilead Sciences (GILD) | 15.8 | $71M | 1.0M | 70.78 | |
| Mylan Nv | 8.6 | $39M | 1.0M | 38.82 | |
| Endo International (ENDPQ) | 7.5 | $34M | 3.0M | 11.17 | |
| Supervalu | 7.3 | $33M | 10M | 3.29 | |
| McKesson Corporation (MCK) | 5.5 | $25M | 150k | 164.54 | |
| Perrigo Company (PRGO) | 5.0 | $23M | 300k | 75.52 | |
| Tenet Healthcare Corporation (THC) | 4.3 | $19M | 1.0M | 19.34 | |
| Impax Laboratories | 3.6 | $16M | 1.0M | 16.10 | |
| BioScrip | 1.8 | $8.2M | 3.0M | 2.72 | |
| Vivus | 1.4 | $6.1M | 5.0M | 1.22 |
